(3S)-4-[1-[6-chloro-1-[3-(trifluoromethyl)phenyl]pyrazolo[5,4-d]pyrimidin-4-yl]azetidin-3-yl]-3-methylmorpholine
C20H20ClF3N6O — CID 156716417
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S)-4-[1-[6-chloro-1-[3-(trifluoromethyl)phenyl]pyrazolo[5,4-d]pyrimidin-4-yl]azetidin-3-yl]-3-methylmorpholine
(3S)-4-[1-[6-chloro-1-[3-(trifluoromethyl)phenyl]pyrazolo[5,4-d]pyrimidin-4-yl]azetidin-3-yl]-3-methylmorpholine (PubChem CID 156716417) has the molecular formula C20H20ClF3N6O and a molecular weight of 452.87 g/mol. Its IUPAC name is (3S)-4-[1-[6-chloro-1-[3-(trifluoromethyl)phenyl]pyrazolo[5,4-d]pyrimidin-4-yl]azetidin-3-yl]-3-methylmorpholine.
Molecular Properties
| Compound Name | (3S)-4-[1-[6-chloro-1-[3-(trifluoromethyl)phenyl]pyrazolo[5,4-d]pyrimidin-4-yl]azetidin-3-yl]-3-methylmorpholine |
|---|---|
| PubChem CID | 156716417 |
| Molecular Formula | C20H20ClF3N6O |
| Molecular Weight | 452.87 g/mol |
| Exact Mass | 452.13 |
| IUPAC Name | (3S)-4-[1-[6-chloro-1-[3-(trifluoromethyl)phenyl]pyrazolo[5,4-d]pyrimidin-4-yl]azetidin-3-yl]-3-methylmorpholine |
| SMILES | C[C@H]1COCCN1C1CN(c2nc(Cl)nc3c2cnn3-c2cccc(C(F)(F)F)c2)C1 |
| InChI | InChI=1S/C20H20ClF3N6O/c1-12-11-31-6-5-29(12)15-9-28(10-15)17-16-8-25-30(18(16)27-19(21)26-17)14-4-2-3-13(7-14)20(22,23)24/h2-4,7-8,12,15H,5-6,9-11H2,1H3/t12-/m0/s1 |
| InChIKey | OWVADORWDVELJC-LBPRGKRZSA-N |
| XLogP | 3.40 |
| TPSA | 59.31 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 452.87 |
| LogP ≤ 5 | 3.40 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156716417 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.